Global Biological Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Biological Drugs market size was valued at USD 291940 million in 2023 and is forecast to a readjusted size of USD 495400 million by 2030 with a CAGR of 7.8% during review period.

The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Biological Drugs industry chain, the market status of Hospitals (Therapeutic Protein, Monoclonal Antibody), Ambulatory Surgical Centers (Therapeutic Protein, Monoclonal Antibody), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biological Drugs.

Regionally, the report analyzes the Biological Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biological Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Biological Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biological Drugs industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Therapeutic Protein, Monoclonal Antibody).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biological Drugs market.

Regional Analysis: The report involves examining the Biological Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biological Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Biological Drugs:
Company Analysis: Report covers individual Biological Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biological Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Centers).

Technology Analysis: Report covers specific technologies relevant to Biological Drugs. It assesses the current state, advancements, and potential future developments in Biological Drugs areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biological Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Biological Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Therapeutic Protein
    Monoclonal Antibody
    Vaccine
    Others

Market segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Others

Major players covered
    Bristol-Myers Squibb
    Eli Lilly
    Takeda
    Pfizer
    Amgen
    F. Hoffmann-La Roche
    Johnson & Johnson
    Merck
    Abbott Laboratories
    Baxter
    Novartis
    Biogen
    GlaxoSmithKline

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biological Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biological Drugs, with price, sales, revenue and global market share of Biological Drugs from 2019 to 2024.
Chapter 3, the Biological Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biological Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Biological Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biological Drugs.
Chapter 14 and 15, to describe Biological Drugs sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Biological Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Biological Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Therapeutic Protein
        1.3.3 Monoclonal Antibody
        1.3.4 Vaccine
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Biological Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals
        1.4.3 Ambulatory Surgical Centers
        1.4.4 Others
    1.5 Global Biological Drugs Market Size & Forecast
        1.5.1 Global Biological Drugs Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Biological Drugs Sales Quantity (2019-2030)
        1.5.3 Global Biological Drugs Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Bristol-Myers Squibb
        2.1.1 Bristol-Myers Squibb Details
        2.1.2 Bristol-Myers Squibb Major Business
        2.1.3 Bristol-Myers Squibb Biological Drugs Product and Services
        2.1.4 Bristol-Myers Squibb Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Bristol-Myers Squibb Recent Developments/Updates
    2.2 Eli Lilly
        2.2.1 Eli Lilly Details
        2.2.2 Eli Lilly Major Business
        2.2.3 Eli Lilly Biological Drugs Product and Services
        2.2.4 Eli Lilly Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Eli Lilly Recent Developments/Updates
    2.3 Takeda
        2.3.1 Takeda Details
        2.3.2 Takeda Major Business
        2.3.3 Takeda Biological Drugs Product and Services
        2.3.4 Takeda Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Takeda Recent Developments/Updates
    2.4 Pfizer
        2.4.1 Pfizer Details
        2.4.2 Pfizer Major Business
        2.4.3 Pfizer Biological Drugs Product and Services
        2.4.4 Pfizer Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Pfizer Recent Developments/Updates
    2.5 Amgen
        2.5.1 Amgen Details
        2.5.2 Amgen Major Business
        2.5.3 Amgen Biological Drugs Product and Services
        2.5.4 Amgen Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Amgen Recent Developments/Updates
    2.6 F. Hoffmann-La Roche
        2.6.1 F. Hoffmann-La Roche Details
        2.6.2 F. Hoffmann-La Roche Major Business
        2.6.3 F. Hoffmann-La Roche Biological Drugs Product and Services
        2.6.4 F. Hoffmann-La Roche Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 F. Hoffmann-La Roche Recent Developments/Updates
    2.7 Johnson & Johnson
        2.7.1 Johnson & Johnson Details
        2.7.2 Johnson & Johnson Major Business
        2.7.3 Johnson & Johnson Biological Drugs Product and Services
        2.7.4 Johnson & Johnson Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Johnson & Johnson Recent Developments/Updates
    2.8 Merck
        2.8.1 Merck Details
        2.8.2 Merck Major Business
        2.8.3 Merck Biological Drugs Product and Services
        2.8.4 Merck Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Merck Recent Developments/Updates
    2.9 Abbott Laboratories
        2.9.1 Abbott Laboratories Details
        2.9.2 Abbott Laboratories Major Business
        2.9.3 Abbott Laboratories Biological Drugs Product and Services
        2.9.4 Abbott Laboratories Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Abbott Laboratories Recent Developments/Updates
    2.10 Baxter
        2.10.1 Baxter Details
        2.10.2 Baxter Major Business
        2.10.3 Baxter Biological Drugs Product and Services
        2.10.4 Baxter Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Baxter Recent Developments/Updates
    2.11 Novartis
        2.11.1 Novartis Details
        2.11.2 Novartis Major Business
        2.11.3 Novartis Biological Drugs Product and Services
        2.11.4 Novartis Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Novartis Recent Developments/Updates
    2.12 Biogen
        2.12.1 Biogen Details
        2.12.2 Biogen Major Business
        2.12.3 Biogen Biological Drugs Product and Services
        2.12.4 Biogen Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Biogen Recent Developments/Updates
    2.13 GlaxoSmithKline
        2.13.1 GlaxoSmithKline Details
        2.13.2 GlaxoSmithKline Major Business
        2.13.3 GlaxoSmithKline Biological Drugs Product and Services
        2.13.4 GlaxoSmithKline Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 GlaxoSmithKline Recent Developments/Updates

3 Competitive Environment: Biological Drugs by Manufacturer
    3.1 Global Biological Drugs Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Biological Drugs Revenue by Manufacturer (2019-2024)
    3.3 Global Biological Drugs Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Biological Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Biological Drugs Manufacturer Market Share in 2023
        3.4.2 Top 6 Biological Drugs Manufacturer Market Share in 2023
    3.5 Biological Drugs Market: Overall Company Footprint Analysis
        3.5.1 Biological Drugs Market: Region Footprint
        3.5.2 Biological Drugs Market: Company Product Type Footprint
        3.5.3 Biological Drugs Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Biological Drugs Market Size by Region
        4.1.1 Global Biological Drugs Sales Quantity by Region (2019-2030)
        4.1.2 Global Biological Drugs Consumption Value by Region (2019-2030)
        4.1.3 Global Biological Drugs Average Price by Region (2019-2030)
    4.2 North America Biological Drugs Consumption Value (2019-2030)
    4.3 Europe Biological Drugs Consumption Value (2019-2030)
    4.4 Asia-Pacific Biological Drugs Consumption Value (2019-2030)
    4.5 South America Biological Drugs Consumption Value (2019-2030)
    4.6 Middle East and Africa Biological Drugs Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Biological Drugs Sales Quantity by Type (2019-2030)
    5.2 Global Biological Drugs Consumption Value by Type (2019-2030)
    5.3 Global Biological Drugs Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Biological Drugs Sales Quantity by Application (2019-2030)
    6.2 Global Biological Drugs Consumption Value by Application (2019-2030)
    6.3 Global Biological Drugs Average Price by Application (2019-2030)

7 North America
    7.1 North America Biological Drugs Sales Quantity by Type (2019-2030)
    7.2 North America Biological Drugs Sales Quantity by Application (2019-2030)
    7.3 North America Biological Drugs Market Size by Country
        7.3.1 North America Biological Drugs Sales Quantity by Country (2019-2030)
        7.3.2 North America Biological Drugs Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Biological Drugs Sales Quantity by Type (2019-2030)
    8.2 Europe Biological Drugs Sales Quantity by Application (2019-2030)
    8.3 Europe Biological Drugs Market Size by Country
        8.3.1 Europe Biological Drugs Sales Quantity by Country (2019-2030)
        8.3.2 Europe Biological Drugs Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Biological Drugs Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Biological Drugs Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Biological Drugs Market Size by Region
        9.3.1 Asia-Pacific Biological Drugs Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Biological Drugs Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Biological Drugs Sales Quantity by Type (2019-2030)
    10.2 South America Biological Drugs Sales Quantity by Application (2019-2030)
    10.3 South America Biological Drugs Market Size by Country
        10.3.1 South America Biological Drugs Sales Quantity by Country (2019-2030)
        10.3.2 South America Biological Drugs Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Biological Drugs Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Biological Drugs Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Biological Drugs Market Size by Country
        11.3.1 Middle East & Africa Biological Drugs Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Biological Drugs Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Biological Drugs Market Drivers
    12.2 Biological Drugs Market Restraints
    12.3 Biological Drugs Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Biological Drugs and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Biological Drugs
    13.3 Biological Drugs Production Process
    13.4 Biological Drugs Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Biological Drugs Typical Distributors
    14.3 Biological Drugs Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Biological Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Biological Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table 4. Bristol-Myers Squibb Major Business
    Table 5. Bristol-Myers Squibb Biological Drugs Product and Services
    Table 6. Bristol-Myers Squibb Biological Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Bristol-Myers Squibb Recent Developments/Updates
    Table 8. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 9. Eli Lilly Major Business
    Table 10. Eli Lilly Biological Drugs Product and Services
    Table 11. Eli Lilly Biological Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Eli Lilly Recent Developments/Updates
    Table 13. Takeda Basic Information, Manufacturing Base and Competitors
    Table 14. Takeda Major Business
    Table 15. Takeda Biological Drugs Product and Services
    Table 16. Takeda Biological Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Takeda Recent Developments/Updates
    Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 19. Pfizer Major Business
    Table 20. Pfizer Biological Drugs Product and Services
    Table 21. Pfizer Biological Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Pfizer Recent Developments/Updates
    Table 23. Amgen Basic Information, Manufacturing Base and Competitors
    Table 24. Amgen Major Business
    Table 25. Amgen Biological Drugs Product and Services
    Table 26. Amgen Biological Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Amgen Recent Developments/Updates
    Table 28. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
    Table 29. F. Hoffmann-La Roche Major Business
    Table 30. F. Hoffmann-La Roche Biological Drugs Product and Services
    Table 31. F. Hoffmann-La Roche Biological Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. F. Hoffmann-La Roche Recent Developments/Updates
    Table 33. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 34. Johnson & Johnson Major Business
    Table 35. Johnson & Johnson Biological Drugs Product and Services
    Table 36. Johnson & Johnson Biological Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Johnson & Johnson Recent Developments/Updates
    Table 38. Merck Basic Information, Manufacturing Base and Competitors
    Table 39. Merck Major Business
    Table 40. Merck Biological Drugs Product and Services
    Table 41. Merck Biological Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Merck Recent Developments/Updates
    Table 43. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
    Table 44. Abbott Laboratories Major Business
    Table 45. Abbott Laboratories Biological Drugs Product and Services
    Table 46. Abbott Laboratories Biological Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Abbott Laboratories Recent Developments/Updates
    Table 48. Baxter Basic Information, Manufacturing Base and Competitors
    Table 49. Baxter Major Business
    Table 50. Baxter Biological Drugs Product and Services
    Table 51. Baxter Biological Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. Baxter Recent Developments/Updates
    Table 53. Novartis Basic Information, Manufacturing Base and Competitors
    Table 54. Novartis Major Business
    Table 55. Novartis Biological Drugs Product and Services
    Table 56. Novartis Biological Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 57. Novartis Recent Developments/Updates
    Table 58. Biogen Basic Information, Manufacturing Base and Competitors
    Table 59. Biogen Major Business
    Table 60. Biogen Biological Drugs Product and Services
    Table 61. Biogen Biological Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 62. Biogen Recent Developments/Updates
    Table 63. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 64. GlaxoSmithKline Major Business
    Table 65. GlaxoSmithKline Biological Drugs Product and Services
    Table 66. GlaxoSmithKline Biological Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 67. GlaxoSmithKline Recent Developments/Updates
    Table 68. Global Biological Drugs Sales Quantity by Manufacturer (2019-2024) & (Units)
    Table 69. Global Biological Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 70. Global Biological Drugs Average Price by Manufacturer (2019-2024) & (USD/Unit)
    Table 71. Market Position of Manufacturers in Biological Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 72. Head Office and Biological Drugs Production Site of Key Manufacturer
    Table 73. Biological Drugs Market: Company Product Type Footprint
    Table 74. Biological Drugs Market: Company Product Application Footprint
    Table 75. Biological Drugs New Market Entrants and Barriers to Market Entry
    Table 76. Biological Drugs Mergers, Acquisition, Agreements, and Collaborations
    Table 77. Global Biological Drugs Sales Quantity by Region (2019-2024) & (Units)
    Table 78. Global Biological Drugs Sales Quantity by Region (2025-2030) & (Units)
    Table 79. Global Biological Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 80. Global Biological Drugs Consumption Value by Region (2025-2030) & (USD Million)
    Table 81. Global Biological Drugs Average Price by Region (2019-2024) & (USD/Unit)
    Table 82. Global Biological Drugs Average Price by Region (2025-2030) & (USD/Unit)
    Table 83. Global Biological Drugs Sales Quantity by Type (2019-2024) & (Units)
    Table 84. Global Biological Drugs Sales Quantity by Type (2025-2030) & (Units)
    Table 85. Global Biological Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 86. Global Biological Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 87. Global Biological Drugs Average Price by Type (2019-2024) & (USD/Unit)
    Table 88. Global Biological Drugs Average Price by Type (2025-2030) & (USD/Unit)
    Table 89. Global Biological Drugs Sales Quantity by Application (2019-2024) & (Units)
    Table 90. Global Biological Drugs Sales Quantity by Application (2025-2030) & (Units)
    Table 91. Global Biological Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 92. Global Biological Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 93. Global Biological Drugs Average Price by Application (2019-2024) & (USD/Unit)
    Table 94. Global Biological Drugs Average Price by Application (2025-2030) & (USD/Unit)
    Table 95. North America Biological Drugs Sales Quantity by Type (2019-2024) & (Units)
    Table 96. North America Biological Drugs Sales Quantity by Type (2025-2030) & (Units)
    Table 97. North America Biological Drugs Sales Quantity by Application (2019-2024) & (Units)
    Table 98. North America Biological Drugs Sales Quantity by Application (2025-2030) & (Units)
    Table 99. North America Biological Drugs Sales Quantity by Country (2019-2024) & (Units)
    Table 100. North America Biological Drugs Sales Quantity by Country (2025-2030) & (Units)
    Table 101. North America Biological Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 102. North America Biological Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 103. Europe Biological Drugs Sales Quantity by Type (2019-2024) & (Units)
    Table 104. Europe Biological Drugs Sales Quantity by Type (2025-2030) & (Units)
    Table 105. Europe Biological Drugs Sales Quantity by Application (2019-2024) & (Units)
    Table 106. Europe Biological Drugs Sales Quantity by Application (2025-2030) & (Units)
    Table 107. Europe Biological Drugs Sales Quantity by Country (2019-2024) & (Units)
    Table 108. Europe Biological Drugs Sales Quantity by Country (2025-2030) & (Units)
    Table 109. Europe Biological Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 110. Europe Biological Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 111. Asia-Pacific Biological Drugs Sales Quantity by Type (2019-2024) & (Units)
    Table 112. Asia-Pacific Biological Drugs Sales Quantity by Type (2025-2030) & (Units)
    Table 113. Asia-Pacific Biological Drugs Sales Quantity by Application (2019-2024) & (Units)
    Table 114. Asia-Pacific Biological Drugs Sales Quantity by Application (2025-2030) & (Units)
    Table 115. Asia-Pacific Biological Drugs Sales Quantity by Region (2019-2024) & (Units)
    Table 116. Asia-Pacific Biological Drugs Sales Quantity by Region (2025-2030) & (Units)
    Table 117. Asia-Pacific Biological Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 118. Asia-Pacific Biological Drugs Consumption Value by Region (2025-2030) & (USD Million)
    Table 119. South America Biological Drugs Sales Quantity by Type (2019-2024) & (Units)
    Table 120. South America Biological Drugs Sales Quantity by Type (2025-2030) & (Units)
    Table 121. South America Biological Drugs Sales Quantity by Application (2019-2024) & (Units)
    Table 122. South America Biological Drugs Sales Quantity by Application (2025-2030) & (Units)
    Table 123. South America Biological Drugs Sales Quantity by Country (2019-2024) & (Units)
    Table 124. South America Biological Drugs Sales Quantity by Country (2025-2030) & (Units)
    Table 125. South America Biological Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 126. South America Biological Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 127. Middle East & Africa Biological Drugs Sales Quantity by Type (2019-2024) & (Units)
    Table 128. Middle East & Africa Biological Drugs Sales Quantity by Type (2025-2030) & (Units)
    Table 129. Middle East & Africa Biological Drugs Sales Quantity by Application (2019-2024) & (Units)
    Table 130. Middle East & Africa Biological Drugs Sales Quantity by Application (2025-2030) & (Units)
    Table 131. Middle East & Africa Biological Drugs Sales Quantity by Region (2019-2024) & (Units)
    Table 132. Middle East & Africa Biological Drugs Sales Quantity by Region (2025-2030) & (Units)
    Table 133. Middle East & Africa Biological Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 134. Middle East & Africa Biological Drugs Consumption Value by Region (2025-2030) & (USD Million)
    Table 135. Biological Drugs Raw Material
    Table 136. Key Manufacturers of Biological Drugs Raw Materials
    Table 137. Biological Drugs Typical Distributors
    Table 138. Biological Drugs Typical Customers
List of Figures
    Figure 1. Biological Drugs Picture
    Figure 2. Global Biological Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Biological Drugs Consumption Value Market Share by Type in 2023
    Figure 4. Therapeutic Protein Examples
    Figure 5. Monoclonal Antibody Examples
    Figure 6. Vaccine Examples
    Figure 7. Others Examples
    Figure 8. Global Biological Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 9. Global Biological Drugs Consumption Value Market Share by Application in 2023
    Figure 10. Hospitals Examples
    Figure 11. Ambulatory Surgical Centers Examples
    Figure 12. Others Examples
    Figure 13. Global Biological Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Biological Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Biological Drugs Sales Quantity (2019-2030) & (Units)
    Figure 16. Global Biological Drugs Average Price (2019-2030) & (USD/Unit)
    Figure 17. Global Biological Drugs Sales Quantity Market Share by Manufacturer in 2023
    Figure 18. Global Biological Drugs Consumption Value Market Share by Manufacturer in 2023
    Figure 19. Producer Shipments of Biological Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 20. Top 3 Biological Drugs Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Top 6 Biological Drugs Manufacturer (Consumption Value) Market Share in 2023
    Figure 22. Global Biological Drugs Sales Quantity Market Share by Region (2019-2030)
    Figure 23. Global Biological Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 24. North America Biological Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 25. Europe Biological Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 26. Asia-Pacific Biological Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 27. South America Biological Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 28. Middle East & Africa Biological Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 29. Global Biological Drugs Sales Quantity Market Share by Type (2019-2030)
    Figure 30. Global Biological Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 31. Global Biological Drugs Average Price by Type (2019-2030) & (USD/Unit)
    Figure 32. Global Biological Drugs Sales Quantity Market Share by Application (2019-2030)
    Figure 33. Global Biological Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 34. Global Biological Drugs Average Price by Application (2019-2030) & (USD/Unit)
    Figure 35. North America Biological Drugs Sales Quantity Market Share by Type (2019-2030)
    Figure 36. North America Biological Drugs Sales Quantity Market Share by Application (2019-2030)
    Figure 37. North America Biological Drugs Sales Quantity Market Share by Country (2019-2030)
    Figure 38. North America Biological Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 39. United States Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Canada Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Mexico Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Europe Biological Drugs Sales Quantity Market Share by Type (2019-2030)
    Figure 43. Europe Biological Drugs Sales Quantity Market Share by Application (2019-2030)
    Figure 44. Europe Biological Drugs Sales Quantity Market Share by Country (2019-2030)
    Figure 45. Europe Biological Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 46. Germany Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. France Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. United Kingdom Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Russia Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Italy Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Asia-Pacific Biological Drugs Sales Quantity Market Share by Type (2019-2030)
    Figure 52. Asia-Pacific Biological Drugs Sales Quantity Market Share by Application (2019-2030)
    Figure 53. Asia-Pacific Biological Drugs Sales Quantity Market Share by Region (2019-2030)
    Figure 54. Asia-Pacific Biological Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 55. China Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Japan Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Korea Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. India Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Southeast Asia Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Australia Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. South America Biological Drugs Sales Quantity Market Share by Type (2019-2030)
    Figure 62. South America Biological Drugs Sales Quantity Market Share by Application (2019-2030)
    Figure 63. South America Biological Drugs Sales Quantity Market Share by Country (2019-2030)
    Figure 64. South America Biological Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 65. Brazil Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Argentina Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 67. Middle East & Africa Biological Drugs Sales Quantity Market Share by Type (2019-2030)
    Figure 68. Middle East & Africa Biological Drugs Sales Quantity Market Share by Application (2019-2030)
    Figure 69. Middle East & Africa Biological Drugs Sales Quantity Market Share by Region (2019-2030)
    Figure 70. Middle East & Africa Biological Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 71. Turkey Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Egypt Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Saudi Arabia Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. South Africa Biological Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. Biological Drugs Market Drivers
    Figure 76. Biological Drugs Market Restraints
    Figure 77. Biological Drugs Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Biological Drugs in 2023
    Figure 80. Manufacturing Process Analysis of Biological Drugs
    Figure 81. Biological Drugs Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Companies Mentioned

Bristol-Myers Squibb
Eli Lilly
Takeda
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline